CBD Concentrates: What Research Shows and What FDA Warns

TABLE OF CONTENTS

Of the health benefits claimed for CBD concentrates, only one has FDA approval: fewer seizures in certain rare epilepsies, with the prescription drug Epidiolex. Evidence for pain, anxiety and cravings is early, and a concentrate simply packs more of a compound into a small amount of product.

The United States began restricting cannabis in the 1930s, and by the 1970s cannabis was placed in Schedule I of the Controlled Substances Act, the category for drugs with no currently accepted medical use. Cannabis had been used as medicine for thousands of years before that, the National Cancer Institute notes. In 2026 that changed in part: marijuana in FDA-approved products, or covered by a state medical marijuana license, moved to Schedule III on April 28, 2026, but it is still a federally controlled substance, and other marijuana stays in Schedule I.

When California first legalized medicinal cannabis in the 1990s, interest in cannabis as medicine grew again. A 2022 count found medical cannabis laws in 38 states plus the District of Columbia, Florida among them; Florida has not legalized adult-use marijuana.

Modern extraction can concentrate parts of the cannabis plant, which raises potency, not proven benefit. Cannabis contains many compounds, including terpenes, that researchers are studying. The two compounds that get the most clinical trials are tetrahydrocannabinol (THC) and cannabidiol (CBD).

THC is responsible for the euphoric high that most people experience when they consume cannabis. CBD does not have the euphoric effect, and it is one of the most-studied compounds from cannabis. Its only FDA-approved form, the prescription drug Epidiolex, is covered under Epilepsy below.

That higher strength in a small amount is the main thing that sets concentrates apart. Claims that they give quicker relief come from sellers, not trials, and vaping carries its own risks. Because a little goes a long way, check how much CBD each serving holds on both the label and the lab report.

What Have CBD Concentrates Been Studied For?

CBD has been studied for a variety of conditions, with very different strength of evidence:

Pain

Some patients report pain relief, but anecdotes are not trials. Most claims that CBD eases pain and inflammation rest on studies in mice and in lab dishes. NIH’s NCCIH describes a 2018 review of 47 studies with 4,743 people that found only a small benefit of cannabis or cannabinoids for chronic pain other than cancer pain.

Obesity

Unlike THC, approved as dronabinol to boost appetite in people with AIDS, CBD lists decreased appetite as a side effect on the Epidiolex label. A 2013 analysis of U.S. survey data linked marijuana use with smaller waist size, but it could not show cause. Weight loss is not an approved or proven use of CBD.

Acne

Acne is one of the skin uses CBD has been studied for in the lab. Claims for eczema, rosacea and dandruff have even less support. A 2014 lab study found CBD reduced oil production and inflammation in human oil-gland cells in a dish, which may be relevant to acne, but that has not been shown on skin in people.

Depression and Anxiety

Anxiety is one of the most studied uses of CBD. NIH’s NCCIH says only a small amount of evidence suggests cannabinoids might reduce anxiety. That evidence comes from a few small studies in people, NCCIH says. A 2011 randomized trial in 24 people with social anxiety disorder found a single dose of CBD reduced anxiety during a simulated public speaking test compared with placebo.

How might CBD act on mood and anxiety? Our bodies naturally produce cannabinoids that help to regulate mood. These cannabinoids bind to CB1 receptors in the brain and to CB2 receptors located throughout the body. A 2019 review of 83 studies found scarce evidence that cannabinoids improve depressive disorders or symptoms.

Epilepsy

Cannabis was described as an anticonvulsant in Western medicine as early as 1839, according to the National Cancer Institute. Parents of children with rare seizure disorders, like Dravet syndrome, pushed for access to CBD, and Epidiolex was later approved for Dravet syndrome.

A small 1980 double-blind study gave CBD to 8 people with epilepsy that drugs no longer controlled: 4 stayed almost free of seizures and 3 improved partly, while 7 placebo patients were unchanged. Larger later trials led to FDA approval of Epidiolex.

Neurodegenerative Disorders

Brain health depends on keeping existing nerve cells working. Unfortunately, the production of new neurons slows as we age. Inflammation is one process researchers link to neurodegeneration, the gradual loss of structure or function in nerve cells.

Cannabinoids have shown protective effects on brain cells in lab and animal studies. But a 2021 Cochrane review of 4 trials in 126 people with dementia found no good evidence that cannabinoids help, and none tested whether CBD prevents or slows the disease.

Addiction

CBD has been tested for addiction in small trials and is still being studied for opioid use disorder and other addictions, but it is not an approved treatment.

With ongoing opioid use, the body can build tolerance, NIDA explains, so the same dose has less effect and some people need a larger dose to get the same effect. In an exploratory 2019 randomized trial in people with heroin use disorder who were not using, CBD reduced cue-triggered cravings, but it has not been approved as a treatment for opioid addiction.

Other early research includes a 2013 pilot trial in 24 smokers, where those given a CBD inhaler for a week smoked about 40% fewer cigarettes, while those given a placebo inhaler showed no change.

What Does the Research Show Overall?

Studies show CBD reduces seizures in certain rare seizure disorders, while evidence for most other uses is early. Outside prescription Epidiolex, CBD products are not FDA-approved, and FDA warns CBD can cause liver injury and affect how other drugs work. CBD rules also differ from state to state, so check local law before you buy or use CBD, especially before carrying it across state lines.

If your state allows medical marijuana, ask your physician whether any product, with THC, CBD or both, fits your condition at all. The idea that cannabis compounds work better together, called the entourage effect, has not been proven in clinical trials. Talk with your doctor before adding any cannabis product to your current treatment.

Last updated October 16, 2026 by the Dr. Green Relief Editorial Team.

Medical review

Medically reviewed by Achilles Kalnoky, M.D.

Reviewed on October 16, 2026.

He is licensed in Florida as a medical doctor, license ME115088, which you can check on the Florida Department of Health license lookup.

His review covers the medical statements in this post and the sources cited for them.

CBD Concentrates: What the Research Shows

What Have CBD Concentrates Been Studied For?